Vivoryon Therapeutics N.V. to Present at Upcoming Conferences

Summary by AI BETAClose X

Vivoryon Therapeutics N.V. will participate in several medical and investor conferences in November 2025. Management will present at the American Society of Nephrology (ASN) Kidney Week in Houston, TX, from November 5-9, with a presentation on November 6 focusing on the correlation of eGFR and pE-CCL2 in older adult patients treated with Varoglutamstat, using data from the VIVIAD Phase 2B trial. Vivoryon will also attend the Jefferies Global Healthcare Conference in London from November 18-20 for 1x1 meetings. Additionally, the company will be present at the Deutsches Eigenkapitalforum in Frankfurt/M, Germany, from November 24-26.

Disclaimer*

UK 100

Latest directors dealings